Rightangled is an award-Winning Health Tech company seed-funded by NHS & regulated by Care Quality Commission. Providing home delivered lab-tests for COVID19, DNA testing for health, diet & fitness - with reports from medical, nutrition & exercise professionals. Featured: CNN, Sky News & Telegraph.
- Launched COVID-19 test. PHE confirmed assay to be >98% accurate
- Featured on CNN, Sky News, LBC, Daily Mail and the Telegraph
- Raising working capital to double team size and deliver sales growth
- Plans to release mobile app end of 2020 and develop AI system
Back in 2017 and with a seed fund from NHS England, we built an online platform that enables medical consultants to provide context onto the patients’ DNA results and self-reported health information, all following a vision to change the way healthcare is delivered to our close family members.
Since then, we have grown from strength to strength and have now released a PCR lab-based test for COVID-19, delivered to users and clients' doorstep. The assay's uptake is massive and we have fulfilled bulk orders for clinics, pharmacies, charities and care homes across the UK. We are now receiving quote requests for larger orders in the 100s of thousands from large corporations. Hence, we are now raising working capital to facilitate the delivery on this demand.
Over the past couple of years, we attained a strategic registration with a medical insurance provider, giving Rightangled clear revenue streams within the medical insurance industry as a regulated facility for screening and diagnostic services.
For our next phase, we aim to expand our products, offering finger-blood tests and continue our growth by localising our testing services in multiple countries (USA, UAE and Saudi Arabia). We are also looking to launch our app and create a powerful AI central system to give instant tailored health, diet and fitness advice, based on our users sample resutls and self-reported health information.
Rightangled team is joined by a firm belief that personalised and preventive medicine is the key to a more efficient and holistic healthcare system.
Abdullah Sabyah - Chairman and CEO
A scientist-entrepreneur and a healthcare professional, also the CQC registered manager of Rightangled and the inventor of a patent-pending technology for nucleic acid testing on a lateral flow assay.
Dr Sibtain Anwar - Non-Executive Medical Director
Senior Lecturer and Cardiac Critical Care Consultant in the Department of Perioperative Medicine at the Bart's Heart Centre - Europe’s largest cardiovascular institution. He also sits on the Pain Medicine Council at the Royal Society of Medicine.
Professor Sir John Cunningham - Lead Science Advisor
Lead Science Advisor, Physician-Scientist (Consultant Nephrologist at The Royal Free Hospital and Professor of Nephrology at UCL Medical School). Active researcher with over I00 papers published in peer-reviewed journals. Honorary Fellow of Trinity Hall, University of Cambridge.